Abstract:Smoking frequently leads to epigenetic alterations, including DNA methylation and histone modifications. The effect that smoking has on the DNA methylation levels at CCGG sites, the expression of trimethylation of histone H3 at lysine 27 (H3K27me3) and enhancer of zeste homolog 2 (EZH2), and their interactions in patients with non-small cell lung cancer (NSCLC) were analyzed. There were a total of 42 patients with NSCLC, 22 with adenocarcinomas and 20 with squamous cell carcinomas enrolled in the present study. Expression of H3K27me3, EZH2 and proliferating cellular nuclear antigen (PCNA) were immunohistochemically detected. DNA methylation at CCGG sites was evaluated via histoendonuclease-linked detection of DNA methylation sites. The apoptotic index of cancerous tissues obtained from patients of different smoking statuses was evaluated via the terminal deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling method. The association with clinicopathological data was calculated relative to different smoking statuses. Compared with the non-smokers, smokers with NSCLC exhibited a significantly lower apoptotic index (P<0.05), and frequently had a lower level of DNA methylation at CCGG sites, lower H3K27me3 expression and a higher EZH2 expression (P<0.05). DNA methylation levels at CCGG sites were negatively correlated to the Brinkman index (P=0.017). Furthermore, there was a parallel association between the H3K27me3 and EZH2 expression levels in the majority of smokers, whereas in the majority of non-smokers, there was a diverging association (P=0.015). There was a diverging association between the PCNA and EZH2 expression levels in the majority of smokers; however, in the majority of non-smokers, there was a parallel association (P=0.048). In addition, the association between the CCGG methylation ratio and immunohistochemical expression of H3K27me3 was a parallel association in the majority of smokers, while in the majority of non-smokers there was a diverging association (P=0.049). Conclusively, patients with NSCLC and different smoking statuses exhibit different epigenetic characteristics. Additionally, DNA methylation levels at the CCGG sites may have the ability to determine associations between the expression levels of H3K27me3, EZH2 and PCNA.

Cigarette Smoking And P16ink4 Alpha Gene Promoter Hypermethylation In Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

The effects of p16 gene methylation on the risk of non-small cell lung cancer

Cigarette Smoking, BPDE-DNA Adducts, and Aberrant Promoter Methylations of Tumor Suppressor Genes (TSGs) in NSCLC from Chinese Population

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Association Between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

Effects Of Methylation Of P16 Gene, Polymorphism Of Gstm1 Gene And Environmental Factors On Susceptibility To Lung Cancer

STUDY ON THE METHYLATION OF P16 GENE AND GENETIC POLYMORPHISM OF GSTM1 GENE RELATED WITH SUSCEPTIBILITY TO NON-SMALL CELL LUNG CANCER

Associations of P16INK4a Promoter Hypermethylation with Squamous Intra-Epithelial Lesion, Cervical Cancer and Their Clinicopathological Features: a Meta-Analysis

Association between P16INK4a Promoter Methylation and HNSCC: A Meta-Analysis of 21 Published Studies

Meta-Analyses Of Gene Methylation And Smoking Behavior In Non-Small Cell Lung Cancer Patients

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Analyses on Expression of Trimethylation of Histone H3 at Lysine 27 and DNA Methylation at CCGG Sites in Smoking and Nonsmoking Non-Small Cell Lung Cancer Patients and Their Clinical Significance.

The Prognostic Value Of P16 Hypermethylation In Cancer: A Meta-Analysis

Value Of P16(Ink4a) And Rassf1a Promoter Hypermethylation In Prognosis Of Patients With Resectable Non-Small Cell Lung Cancer

Analysis of H3K27me3 expression and DNA methylation at CCGG sites in smoking and non-smoking patients with non-small cell lung cancer and their clinical significance.

The Relationship Between Promoter Methylation of P16 Gene and Bladder Cancer Risk: a Meta-Analysis.

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Exploring the Cross-Cancer Effect of Smoking and Its Fingerprints in Blood DNA Methylation on Multiple Cancers: A Mendelian Randomization Study

Clinical Analysis of Methylation of p16 Gene in Non-small Cell Lung Cancer